Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
10.43
-0.28 (-2.61%)
Feb 21, 2025, 4:00 PM EST - Market closed
Evolent Health Market Cap
Evolent Health has a market cap or net worth of $1.20 billion as of February 21, 2025. Its market cap has decreased by -64.54% in one year.
Market Cap
1.20B
Enterprise Value
1.81B
1-Year Change
-64.54%
Ranking
Category
Stock Price
$10.43
Market Cap Chart
Since June 5, 2015, Evolent Health's market cap has increased from $1.05B to $1.20B, an increase of 14.11%. That is a compound annual growth rate of 1.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 1.25B | -4.80% |
| Dec 31, 2024 | 1.31B | -65.47% |
| Dec 29, 2023 | 3.80B | 33.63% |
| Dec 30, 2022 | 2.84B | 14.85% |
| Dec 31, 2021 | 2.47B | 79.93% |
| Dec 31, 2020 | 1.38B | 79.57% |
| Dec 31, 2019 | 765.70M | -53.32% |
| Dec 31, 2018 | 1.64B | 72.46% |
| Dec 29, 2017 | 951.20M | -5.38% |
| Dec 30, 2016 | 1.01B | 40.70% |
| Dec 31, 2015 | 714.50M | -32.05% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 801.31B |
| UnitedHealth Group | 421.12B |
| Johnson & Johnson | 389.43B |
| Novo Nordisk | 370.84B |
| AbbVie | 357.06B |
| Abbott Laboratories | 234.25B |
| AstraZeneca | 227.07B |
| Merck & Co. | 224.40B |